iStat Biomedical Co., Ltd. - Epigene

iStat, Epigene, Epigenebio, Cervical cancer test, Oral cancer test, Cancer methylation test, Epigenetic IVD assay, Non-invasive early cancer detection, DNA Methylatoin, 日祥, 甲基化基因檢測, 癌症基因檢測

iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.

Latest News - #Clinical Research

Potential Biomarker for Cervical Cancer Screening

PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening Paper published: PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening PAX1 methylation showed great potential as a biomarker for cervical cancer screening. When incorporating PAX1 methylation detectio ...

A Taiwanese Gynecologic Oncology Group (TGOG) study.

PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Taiwanese Gynecologic Oncology Group (TGOG)  validated the adjunct role of DNA methylation levels in the detection of CIN3+ lesions in Cancer Medicine. Paper published: PA ...
iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.
en